Curaleaf Q3 2026 net loss narrows 42% year over year to USD 32.72 million
Curaleaf reported a third-quarter 2026 net loss attributable to shareholders of USD 32.72 million, down 43% year over year, while net revenue rose 11% to USD 352.65 million.
1. Quarterly results
Curaleaf’s third-quarter 2026 net loss attributable to shareholders narrowed 43% year over year to USD 32.72 million. Net revenue increased 11% to USD 352.65 million.
2. Aurora offer
Following the quarter, Curaleaf raised its acquisition offer for Aurora and is evaluating options after Aurora announced an alternative merger with Organigram.
